Institution
Sungkyunkwan University
Education•Seoul, South Korea•
About: Sungkyunkwan University is a education organization based out in Seoul, South Korea. It is known for research contribution in the topics: Graphene & Thin film. The organization has 28229 authors who have published 56428 publications receiving 1352733 citations. The organization is also known as: 성균관대학교.
Topics: Graphene, Thin film, Population, Carbon nanotube, Layer (electronics)
Papers published on a yearly basis
Papers
More filters
••
22 Apr 2008TL;DR: This paper introduces CHEF - cluster head election mechanism using fuzzy logic, and proves efficiency of CHEF compared with LEACH using the matlab, showing that CHEF is about 22.7% more efficient than LEACH.
Abstract: In designing the wireless sensor networks, the energy is the most important consideration because the lifetime of the sensor node is limited by the battery of it. To overcome this demerit many research have been done. The clustering is the one of the representative approaches. In the clustering, the cluster heads gather data from nodes, aggregate it and send the information to the base station. In this way, the sensor nodes can reduce communication overheads that may be generated if each sensor node reports sensed data to the base station independently. LEACH is one of the most famous clustering mechanisms. It elects a cluster head based on probability model. This approach may reduce the network lifetime because LEACH does not consider the distribution of sensor nodes and the energy remains of each node. However, using the location and the energy information in the clustering can generate big overheads. In this paper we introduce CHEF - cluster head election mechanism using fuzzy logic. By using fuzzy logic, collecting and calculating overheads can be reduced and finally the lifetime of the sensor networks can be prolonged. To prove efficiency of CHEF, we simulated CHEF compared with LEACH using the matlab. Our simulation results show that CHEF is about 22.7% more efficient than LEACH.
480 citations
••
TL;DR: These findings show that a capacitive triboelectric electret is the first technology able to compete with piezoelectricsity to harvest ultrasound in vivo and to power medical implants.
Abstract: A major challenge for implantable medical systems is the inclusion or reliable delivery of electrical power. We use ultrasound to deliver mechanical energy through skin and liquids and demonstrate a thin implantable vibrating triboelectric generator able to effectively harvest it. The ultrasound can induce micrometer-scale displacement of a polymer thin membrane to generate electrical energy through contact electrification. We recharge a lithium-ion battery at a rate of 166 microcoulombs per second in water. The voltage and current generated ex vivo by ultrasound energy transfer reached 2.4 volts and 156 microamps under porcine tissue. These findings show that a capacitive triboelectric electret is the first technology able to compete with piezoelectricity to harvest ultrasound in vivo and to power medical implants.
479 citations
••
University of British Columbia1, Jagiellonian University2, Memorial Sloan Kettering Cancer Center3, Mayo Clinic4, Sungkyunkwan University5, University of Debrecen6, University of Naples Federico II7, University of Texas MD Anderson Cancer Center8, Rutgers University9, Washington University in St. Louis10, Curie Institute11, City of Hope National Medical Center12, University of Bologna13, The Royal Marsden NHS Foundation Trust14, Seattle Genetics15, Takeda Pharmaceutical Company16, University of Manchester17
TL;DR: A+AVD had superior efficacy to ABVD in the treatment of patients with advanced‐stage Hodgkin's lymphoma, with a 4.9 percentage‐point lower combined risk of progression, death, or noncomplete response and use of subsequent anticancer therapy at 2 years.
Abstract: Background Brentuximab vedotin is an anti-CD30 antibody–drug conjugate that has been approved for relapsed and refractory Hodgkin’s lymphoma. Methods We conducted an open-label, multicenter, randomized phase 3 trial involving patients with previously untreated stage III or IV classic Hodgkin’s lymphoma, in which 664 were assigned to receive brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) and 670 were assigned to receive doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). The primary end point was modified progression-free survival (the time to progression, death, or noncomplete response and use of subsequent anticancer therapy) as adjudicated by an independent review committee. The key secondary end point was overall survival. Results At a median follow-up of 24.6 months, 2-year modified progression-free survival rates in the A+AVD and ABVD groups were 82.1% (95% confidence interval [CI], 78.8 to 85.0) and 77.2% (95% CI, 73.7 to 80.4), respectively, a difference of...
479 citations
••
VU University Medical Center1, Maastricht University2, University of California, Berkeley3, Helen Wills Neuroscience Institute4, University of California, San Francisco5, Seoul National University6, Sungkyunkwan University7, Paris Descartes University8, Washington University in St. Louis9, Leipzig University10, Neuroscience Research Australia11, Katholieke Universiteit Leuven12, University of Cologne13, Technische Universität München14, University of Cantabria15, The Chinese University of Hong Kong16, François Rabelais University17, University of Pittsburgh18, Thomas Jefferson University19, University of Copenhagen20, Avid Radiopharmaceuticals21, University of Pennsylvania22, Karolinska Institutet23, Turku University Hospital24, French Institute of Health and Medical Research25, Autonomous University of Barcelona26, Copenhagen University Hospital27, University of Texas at Dallas28, University of Texas Southwestern Medical Center29
TL;DR: Findings indicate the potential clinical utility of amyloid imaging for differential diagnosis in early-onset dementia and to support the clinical diagnosis of participants with AD dementia and noncarrier APOE ε4 status.
Abstract: Importance Amyloid-β positron emission tomography (PET) imaging allows in vivo detection of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its diagnostic utility is still unclear because amyloid plaques also occur in patients with non–AD dementia. Objective To use individual participant data meta-analysis to estimate the prevalence of amyloid positivity on PET in a wide variety of dementia syndromes. Data Sources The MEDLINE and Web of Science databases were searched from January 2004 to April 2015 for amyloid PET studies. Study Selection Case reports and studies on neurological or psychiatric diseases other than dementia were excluded. Corresponding authors of eligible cohorts were invited to provide individual participant data. Data Extraction and Synthesis Data were provided for 1359 participants with clinically diagnosed AD and 538 participants with non–AD dementia. The reference groups were 1849 healthy control participants (with amyloid PET) and an independent sample of 1369 AD participants (with autopsy data). Main Outcomes and Measures Estimated prevalence of positive amyloid PET scans according to diagnosis, age, and apolipoprotein E (APOE) e4 status, using the generalized estimating equations method. Results The likelihood of amyloid positivity was associated with age and APOE e4 status. In AD dementia, the prevalence of amyloid positivity decreased from age 50 to 90 years in APOE e4 noncarriers (86% [95% CI, 73%-94%] at 50 years to 68% [95% CI, 57%-77%] at 90 years; n = 377) and to a lesser degree in APOE e4 carriers (97% [95% CI, 92%-99%] at 50 years to 90% [95% CI, 83%-94%] at 90 years; n = 593; P Conclusions and Relevance Among participants with dementia, the prevalence of amyloid positivity was associated with clinical diagnosis, age, and APOE genotype. These findings indicate the potential clinical utility of amyloid imaging for differential diagnosis in early-onset dementia and to support the clinical diagnosis of participants with AD dementia and noncarrier APOE e4 status who are older than 70 years.
479 citations
••
TL;DR: In this paper, Fowler-Nordheim tunneling was used for atomically flat and ultrathin hexagonal boron nitride (h-BN) on gold-coated mica using conductive atomic force microscopy.
Abstract: Electron tunneling through atomically flat and ultrathin hexagonal boron nitride (h-BN) on gold-coated mica was investigated using conductive atomic force microscopy. Low-bias direct tunneling was observed in mono-, bi-, and tri-layer h-BN. For all thicknesses, Fowler-Nordheim tunneling (FNT) occurred at high bias, showing an increase of breakdown voltage with thickness. Based on the FNT model, the barrier height for tunneling (3.07 eV) and dielectric strength (7.94 MV/cm) of h-BN are obtained; these values are comparable to those of SiO2.
476 citations
Authors
Showing all 28506 results
Name | H-index | Papers | Citations |
---|---|---|---|
Michael Grätzel | 248 | 1423 | 303599 |
Hyun-Chul Kim | 176 | 4076 | 183227 |
Yongsun Kim | 156 | 2588 | 145619 |
David J. Mooney | 156 | 695 | 94172 |
Jongmin Lee | 150 | 2257 | 134772 |
Byung-Sik Hong | 146 | 1557 | 105696 |
Inkyu Park | 144 | 1767 | 109433 |
Y. Choi | 141 | 1631 | 98709 |
Kazunori Kataoka | 138 | 908 | 70412 |
E. J. Corey | 136 | 1377 | 84110 |
Pasi A. Jänne | 136 | 685 | 89488 |
Suyong Choi | 135 | 1495 | 97053 |
Intae Yu | 134 | 1372 | 89870 |
Tae Jeong Kim | 132 | 1420 | 93959 |
Anders Hagfeldt | 129 | 600 | 79912 |